Breath analysis using electronic nose and gas chromatography-mass spectrometry

Background and aims: In this work, breath samples from clinically stable bronchiectasis patients with and without bronchial infections by Pseudomonas Aeruginosa- PA) were collected and chemically analysed to determine if they have clinical value in the monitoring of these patients. Materials and met...

Descripción completa

Detalles Bibliográficos
Autores: Fontes de Oliveira, Luciana, Mallafré-Muro, Celia, Giner, Jordi|||0000-0002-3044-2059, Perea, Lidia|||0000-0002-1624-0012, Sibila, Oriol|||0000-0002-4833-6713, Pardo, Antonio|||0000-0003-4369-544X, Marco, Santiago
Tipo de recurso: artículo
Fecha de publicación:2022
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:284449
Acceso en línea:https://ddd.uab.cat/record/284449
https://dx.doi.org/urn:doi:10.1016/j.cca.2021.12.019
Access Level:acceso abierto
Palabra clave:Breath analysis
Bronchiectasis
Signal processing
E-nose
GC-MS
Descripción
Sumario:Background and aims: In this work, breath samples from clinically stable bronchiectasis patients with and without bronchial infections by Pseudomonas Aeruginosa- PA) were collected and chemically analysed to determine if they have clinical value in the monitoring of these patients. Materials and methods: A cohort was recruited inviting bronchiectasis patients (25) and controls (9). Among the former group, 12 members were suffering PA infection. Breath samples were collected in Tedlar bags and analyzed by e-nose and Gas Chromatography-Mass Spectrometry (GC-MS). The obtained data were analyzed by chemometric methods to determine their discriminant power in regards to their health condition. Results were evaluated with blind samples. Results: Breath analysis by electronic nose successfully separated the three groups with an overall classification rate of 84% for the three-class classification problem. The best discrimination was obtained between control and bronchiectasis with PA infection samples 100% (CI: 84-100%) on external validation and the results were confirmed by permutation tests. The discrimination analysis by GC-MS provided good results but did not reach proper statistical significance after a permutation test. Conclusions: Breath sample analysis by electronic nose followed by proper predictive models successfully differentiated between control, Bronchiectasis and Bronchiectasis PA samples.